The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting
Status:
Active, not recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of Aprepitant + standard antiemetic
regimen in reducing postoperative nausea and vomiting after laparoscopic gastric sleeve
versus placebo + standard antiemetic regimen